NEW DELHI: Total recoveries from COVID-19 in India crossed the 50 lakh milestone on Monday with recovered cases outpacing active cases by more than five times, the Union Health ministry said.

In a statement, the ministry said the rise in the number of total recovered cases from 1 lakh in June 2020 has been steep and the last 10 lakh recoveries were added in just 11 days.

“India’s total recoveries have crossed the landmark milestone of 50 lakh today (50,16,520). With a very high number of COVID patients recovering every single day, India’s steady trend of posting high level of daily recoveries continues,” the ministry said.

“The total recovered cases have outpaced active cases by more than 5 times. With the exponential increase in the recoveries, there is close to 100 per cent increase in recovered cases in one month,” it said.

Noting that 15 States/UTs are showing recovery rate more than the national average, the ministry said 78 per cent of the total recovered cases are recorded in 10 States/UTs with Maharashtra contributing maximum to the total recovered cases followed by Andhra Pradesh and Tamil Nadu.

“Seventy-three per cent of the new recovered cases are being reported from ten states, viz. Maharashtra, Karnataka, Andhra Pradesh, Uttar Pradesh and Tamil Nadu, Delhi, Kerala, Odisha, West Bengal and Punjab. Maharashtra leads the tally with more than 13,000 new cases of recovered patients,” it said.

The ministry further said that 84 per cent of new deaths are reported from 10 States and UTs.

It said 36 per cent of deaths reported on Sunday are from Maharashtra at 380 deaths followed by Tamil Nadu and Karnataka with 80 and 79 deaths, respectively.

The ministry reiterated its call for strict adherence of norms of physical distancing, following hand hygiene and respiratory etiquette, and use of mask/face covers in public spaces.

India’s COVID-19 tally galloped past 60 lakh on Monday with 82,170 new cases, while the recoveries have surged to 50.17 lakh with 74,893 more people having recuperated, the Health Ministry said.

The death toll from the disease climbed to 95,542 with 1,039 more deaths.

There are 9,62,640 active cases of coronavirus disease (COVID-19) in the country, comprising 15.85 per cent of the total caseload, according to the ministry data.

The total coronavirus cases mounted to 60,74,702, while 50,16,520 people have recuperated from the virus, taking the recovery rate to 82.58 per cent.

The case fatality rate declined to 1.57 per cent, it said.

New Delhi: India’s COVID-19 tally sprinted past 59 lakh with 85,362 fresh cases in a span of 24 hours, while over 48 lakh people have recovered from the disease so far, according to the Union Health Ministry’s data updated on Saturday.

The total coronavirus cases rose to 59,03,932 with 85,362 infections being reported in a day, while the death toll reached 93,379 after 1,089 people succumbed to the disease in a span of 24 hours, the data updated at 8 am showed.

The total recoveries surged to 48,49,584 in the country, pushing the nation’s recovery rate to 82.14 per cent. The COVID-19 case fatality rate was recorded at 1.58 per cent.

There are 9,60,969 active cases in the country which comprise 16.28 per cent of the total caseload, the data stated.

India’s COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23, 40 lakh on September 5 and it went past 50 lakh on September 16.

According to the ICMR, a cumulative total of 7,02,69,975 samples have been tested up to September 25 with 13,41,535 samples being tested on Friday.

All candidates found coronavirus positive or currently under medical surveillance will not be permitted to appear for CLAT 2020 on September 28, the new guidelines stated.

India tally crossed the 56-lakh mark with a spike of 83,347 new cases and 1,085 deaths in the last 24 hours.

The total case tally in the country now stands at 5,646,011 including 9,68,377 active cases, 45,87,614 cured/discharged/migrated  and 90,020 deaths, Health Ministry’s latest update informed.

Reporting more cases of recovered ones over fresh infections for four consecutive days, India also recorded over one lakh recoveries for the first time yesterday.

On the progress front, Mumbai’s KEM Hospital has received to conduct clinical trials of Oxford COVID-19 vaccine candidate ‘Covishield’, the process of screening volunteers for which, are set to commence from today.

The death toll climbed to 88,935 as the virus claimed 1,053 more lives during the same period, according to the data updated at 8 am.

NEW DELHI: India’s COVID-19 infection tally crossed 55 lakh on Tuesday, while a record 1,01,468 patients recovered in a day, taking their number to 44,97,867 and pushing the recovery rate to 80.86 per cent, the Union health ministry data showed.

The coronavirus caseload in the country surged to 55,62,663, with 75,083 new infections being reported in a span of 24 hours, while the death toll climbed to 88,935 as the virus claimed 1,053 more lives during the same period, according to the data updated at 8 am.

The COVID-19 case fatality rate was recorded at 1.60 per cent.

There are 9,75,861 active cases of the coronavirus infection in the country which comprises 17.54 per cent of the total caseload, the data stated.

India’s COVID-19 tally had crossed the 20-lakh mark on August 7, 30 lakh on August 23, 40 lakh on September 5, and it went past 50 lakh on September 16.

According to the Indian Council of Medical Research, a cumulative total of 6,53,25,779 samples have been tested up to September 21, with 9,33,185 samples being tested on Monday.

With the latest inclusions, the total caseload mounted to 53,08,014 and the recoveries to 42,08,431, pushing the recovery rate to 79.28 per cent.

NEW DELHI: India’s single-day recovery outstripped the number of new infections as nearly 96,000 people recuperated from the novel coronavirus, even as the total number of cases went past 53 lakh, according to the Union Health Ministry data on Saturday.

The figures updated at 8 am showed that while 95,880 people recovered from the virus in a span of 24 hours, 93,337 new infections were recorded during the period.

With the latest inclusions, the total caseload mounted to 53,08,014 and the recoveries to 42,08,431, pushing the recovery rate to 79.28 per cent.

The death toll, meanwhile, climbed to 85,619 with the virus claiming 1,247 lives in a span of 24 hours, the updated data showed.

The COVID-19 case fatality rate has further dropped at 1.61 per cent, the data showed.

There are 10,13,964 active cases of COVID-19 in the country, which constitute 19.10 per cent of the total caseload, the data stated.

The country’s COVID-19 tally had crossed the 20-lakh mark on August 7, the 30-lakh mark on August 23, 40 lakh on September 5, and it went past 50 lakh on September 16.

According to the Indian Council of Medical Research, a cumulative 6,24,54,254 COVID-19 samples have been tested up to September 18 — 8,81,911 of them on Friday.

According to the Ministry of Health and Family Welfare data, 13 states and union territories currently got less than 5,000 active cases.

India’s COVID-19 tally raced past 52 lakh with 96,424 people testing positive in a day, while the number of people who have recuperated from the disease rose to 41,12,551 on Friday, according to the Union Health Ministry data.

The total coronavirus cases mounted to 52,14,677, while the death toll climbed to 84,372 with the virus claiming 1,174 lives in a span of 24 hours, the data updated at 8 am showed.

There are 10,17,754 active cases of COVID-19 in the country which comprises 19.52 per cent of the total caseload, the data stated.

Upon regulatory approval in India, Russia’s sovereign wealth fund will supply 100 million doses of the vaccine to Dr Reddy’s Laboratories.

HYDERABAD/MOSCOW: Dr Reddy’s Laboratories and Russian Direct Investment Fund (RDIF) have agreed to cooperate on clinical trials and distribution of Sputnik V vaccine in India.

Upon regulatory approval in India, Russia’s sovereign wealth fund will supply 100 million doses of the vaccine to Dr Reddy’s.

The Sputnik V vaccine, which is based on well-studied human adenoviral vector platform with proven safety, is undergoing clinical trials for the coronavirus pandemic.

Deliveries could potentially begin in late 2020 subject to completion of successful trials and registration of the vaccine by regulatory authorities in India.

The agreement between RDIF and Dr Reddy’s reflects growing awareness of countries and organisations to have a diversified anti-Covid vaccine portfolio to protect their populations.

“India is among the most severely impacted countries from Covid-19 and we believe our human adenovirus dual vector platform will provide a safe and scientifically validated option to India in the battle against it,” said Kirill Dmitriev, Chief Executive Officer of RDIF.

G V Prasad, Co-Chairman and Managing Director of Dr Reddy’s said Sputnik V vaccine could provide a credible option in our fight against Covid-19 in India.

“The phase one and two clinical trials have shown promising results. We will be conducting phase three trials in India to ensure safety and efficacy for the Indian population,” he said in a statement.